| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2013 | CN102058574B Use of fumaric acid derivatives for treating cardiac insufficiency |
| 02/13/2013 | CN102046141B External preparation for skin |
| 02/13/2013 | CN102040538B Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 02/13/2013 | CN102038646B Sugar-free cefprozil dry suspension and preparation method thereof |
| 02/13/2013 | CN102030802B Adamantine amino tea sapogenol as well as preparation method and application thereof |
| 02/13/2013 | CN102028696B New application of prostaglandin compounds |
| 02/13/2013 | CN102002001B 2,2'-(1,4-phenylene) di(benzimidazole-5-carboxylic acid) and preparation method thereof |
| 02/13/2013 | CN101984963B Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma |
| 02/13/2013 | CN101952260B 4, 5-dihydro-oxazol-2-yl amine derivatives |
| 02/13/2013 | CN101940569B Medicament composition containing sorafenib, artemisinin and artemisinin derivative and application thereof in preparing medicament for treating cancer |
| 02/13/2013 | CN101928253B 2-[5-(2-hydroxyphenyl]-4H-1,2,4-triazole-3-thioether]-1-acetophenone compound or pharmaceutically acceptable salt and preparation and application thereof |
| 02/13/2013 | CN101926996B Application of methotrexate and ABC inhibitor to preparation of medicament for treating psoriasis |
| 02/13/2013 | CN101918364B Composition and method for treating proteinuria |
| 02/13/2013 | CN101880308B New hopane-type triterpene and preparation method and application thereof |
| 02/13/2013 | CN101868457B (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 02/13/2013 | CN101868232B Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same |
| 02/13/2013 | CN101849936B Vaginal health products |
| 02/13/2013 | CN101844994B Gossypol amino-acid derivative for blocking invasion of human immunodeficiency viruses and preparation method and application thereof |
| 02/13/2013 | CN101837128B Medicament composition containing sorafenib, MEK inhibitors and EGFR tyrosine kinase inhibitors and application thereof |
| 02/13/2013 | CN101836989B Medicament composition containing tetrandrine, tetrandrine derivatives and histone deacetylase inhibitor and application thereof |
| 02/13/2013 | CN101816643B Medicament composition containing diclofenac sodium and acetaminophen |
| 02/13/2013 | CN101810847B Inflammation-inhibiting compounds |
| 02/13/2013 | CN101808999B Quinoline derivatives as 5HT5A receptor antagonists |
| 02/13/2013 | CN101804196B Soybean-based whole protein type enteral nutrition powder and preparation method thereof |
| 02/13/2013 | CN101775059B Novel glycyrrhetinic acid derivative, and preparation method and medicinal uses thereof |
| 02/13/2013 | CN101766573B Preparation process of clopidogrel bisulfate solid preparation |
| 02/13/2013 | CN101744767B Thermal sensitive liposome preparation containing camptothecin antineoplastic agents |
| 02/13/2013 | CN101712676B Water soluble puerarin derivatives and preparation method and application thereof |
| 02/13/2013 | CN101712594B 2-cyclohexyl-5-(1,1- dimethyl octyl) phenol and synthesizing method thereof |
| 02/13/2013 | CN101674804B Ophthalmic oil-in-water emulsions containing prostaglandins |
| 02/13/2013 | CN101653608B Pharmaceutical composition containing hepatocyte growth factor receptor inhibitor and histone deacetylase inhibitor and application thereof |
| 02/13/2013 | CN101653607B Pharmaceutical composition containing hepatocyte growth factor receptor inhibitor and mitogen extracellular kinase inhibitor and application thereof |
| 02/13/2013 | CN101653606B Pharmaceutical composition containing protein kinase B inhibitor and epidermal growth factor recipient tyrosine kinase inhibitor and application thereof |
| 02/13/2013 | CN101631466B Novel palladium complexes inhibit N-myristoyltransferase activity in vitro and cancer growth in vivo |
| 02/13/2013 | CN101624414B Nitrate medicament for inhibiting angiogenesis |
| 02/13/2013 | CN101548683B Liquid disinfectant and method of producing the same |
| 02/13/2013 | CN101537187B Anthocyanin phospholipids compound and preparation method thereof |
| 02/13/2013 | CN101534852B Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 02/13/2013 | CN101528734B 3 -amino- pyridine derivatives for the treatment of metabolic disorders |
| 02/13/2013 | CN101505730B Compositions comprising calcium citrate malate and methods for making the same |
| 02/13/2013 | CN101490035B Amino-piperidine derivatives as CETP inhibitors |
| 02/13/2013 | CN101489537B Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 02/13/2013 | CN101485824B Chinese medicament preparation for tonifying kidney and benefiting brain as well as preparation method and novel use thereof |
| 02/13/2013 | CN101484125B Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| 02/13/2013 | CN101445469B Inhibitors of histone deacetylase |
| 02/13/2013 | CN101439015B Pharmaceutical composition with enhanced bioavailability |
| 02/13/2013 | CN101426485B Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nthe |
| 02/13/2013 | CN101379057B Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl es |
| 02/13/2013 | CN101357223B Preparation method of anti-stress agent for fishing |
| 02/13/2013 | CN101355986B Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful thereof |
| 02/13/2013 | CN101327201B Gossypol or liquid preparation of analogue thereof and preparation method and use thereof |
| 02/13/2013 | CN101325973B Use of oligouronates for treating mucus hyperviscosity |
| 02/13/2013 | CN101291939B Thiazolo[4,5-C]pyridine derivatives as mGluR5 receptor antagonists |
| 02/13/2013 | CN101282940B Fluorinated compounds |
| 02/13/2013 | CN101259113B Etodolac osmotic pump type controlled-release preparation and preparation thereof |
| 02/13/2013 | CN101245043B Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 02/13/2013 | CN101222900B Proteasome inhibitors and uses thereof |
| 02/13/2013 | CN101203145B Treating keratinous dryness using glycerides |
| 02/13/2013 | CN101100470B Tetranuclear bipyrane coumarin compound |
| 02/13/2013 | CN101098689B Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 02/13/2013 | CN101052312B Compositions for improving oxidative status in companion animals |
| 02/12/2013 | US8373006 Anti-leishmanial compound and anti-leishmanial drug |
| 02/12/2013 | US8372995 For parental administration |
| 02/12/2013 | US8372992 Strontium (M) ascorbate, compositions containing same, method for making same and method of using same |
| 02/12/2013 | US8372990 Bicyclic tetrahydropyrrole compounds |
| 02/12/2013 | US8372984 Dual-acting oxazole antihypertensive agents |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372980 Fused ring thrombin receptor antagonists |
| 02/12/2013 | US8372978 Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate |
| 02/12/2013 | US8372973 Prokineticin 1 receptor antagonists |
| 02/12/2013 | US8372971 Heterocyclic compounds and methods of use |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372967 Compounds and methods for modulating expression of GCCR |
| 02/12/2013 | US8372933 Hyperbranched polymers based on cyclodextrins and poly (amidoamines) for the controlled release of insoluble drugs |
| 02/12/2013 | US8372890 Functional food containing sodium tricaffeoylaldarate |
| 02/12/2013 | US8372889 Methods for modulating metabolism |
| 02/12/2013 | US8372888 Sphingosine kinase type 1 inhibitors, compositions and processes for using same |
| 02/12/2013 | US8372887 Trans-clomiphene for metabolic syndrome |
| 02/12/2013 | US8372885 Organic compounds and their uses |
| 02/12/2013 | US8372884 Isoprenyl compounds and methods thereof |
| 02/12/2013 | US8372883 Methods of using cycloalkylmethylamines |
| 02/12/2013 | US8372881 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 02/12/2013 | US8372880 Compositions and methods using same for treating amyloid-associated diseases |
| 02/12/2013 | US8372879 4-(heterocycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
| 02/12/2013 | US8372878 Aminoguanidines as melanocortin receptor ligands |
| 02/12/2013 | US8372877 Stabilized statin formulations |
| 02/12/2013 | US8372876 Method for improving memory in mammals |
| 02/12/2013 | US8372875 Indole carboxamides as IKK2 inhibitors |
| 02/12/2013 | US8372874 Compounds which selectively modulate the CB2 receptor |
| 02/12/2013 | US8372873 Inhibitors of serine proteases |
| 02/12/2013 | US8372872 Methods for concomitant treatment of theophylline and febuxostat |
| 02/12/2013 | US8372871 Histidinol dehydrogenase inhibitors, and use thereof as medicaments |
| 02/12/2013 | US8372870 Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer |
| 02/12/2013 | US8372869 Process for the treatment of bacterial infections using 2-phenyl-1,2-benzisoselenazol-3(2H)-one 1-oxide |
| 02/12/2013 | US8372866 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain |
| 02/12/2013 | US8372865 Dihydropyridone amides as P2X7 modulators |
| 02/12/2013 | US8372864 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 02/12/2013 | US8372863 Tetrahydro-1H-pyrrolo fused pyridones |
| 02/12/2013 | US8372862 Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative |
| 02/12/2013 | US8372861 Inhibitors of the unfolded protein response and methods for their use |